Home Internet of Things Aerospace Apparel Energy Defense Health Care Logistics Manufacturing Retail

U.S. Senate Bill Proposes Technology to Authenticate Drugs

An amendment passed last week specifying several authentication technologies without mentioning RFID. Some experts say the legislation is confusing.
By Beth Bacheldor
May 18, 2007The U.S. Senate passed a bill last week that includes an amendment calling for drug authentication technologies to help improve the safety of pharmaceuticals sold on the Internet. However, some confusion exists as to exactly which types of technologies, if passed, the amendment would require.

Authored by Senator Michael Enzi (R-Wyo.), the amendment was added to the Safe Internet Pharmacy Act of 2007, introduced in the spring by U.S. Senator Judd Gregg (R-N.H.), a member of the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP), as well as Senator Gordon Smith (R-Ore.). That act, designed to regulate Internet pharmacies, was a provision rolled into Food and Drug Administration Revitalization Act (S.1082). S.1082 reauthorizes the Prescription Drug User Fee Act (PDUFA), a law requiring drug companies to pay a fee that finances the U.S. Food and Drug Administration's infrastructure for testing and approving drugs (see Two U.S. Bills Might Lead to RFID Mandates). The PDUFA expires on Sept. 30. Congress is expected to reauthorize the act, but the FDA would have no money to continue operating Congress it failed to do so.

Enzi's amendment calls for a specific drug-authentication technology—something the Safe Internet Pharmacy Act of 2007 did not do. Instead, that act calls for Internet pharmacies "to affix to each shipping container of drugs to be shipped in the United States such markings as the Secretary [of Health and Human Services] determines to be necessary to identify that the shipment is from a licensed Internet pharmacy, which may include anticounterfeiting or track-and-trace technologies."

Enzi's amendment, however, demands that drugs sold on the Internet have "overt optically variable counterfeit-resistant technologies that are visible to the naked eye, providing for visual identification of product authenticity without the need for readers, microscopes, lighting devices or scanners." The amendment refers to technologies that "are similar to that used by the Bureau of Engraving and Printing to secure United States currency," such as microdots and holograms.

The second part of the amendment provides an alternative, allowing drugs sold on the Internet to be authenticated by means of technologies utilizing a security function comparable to that described above.

Craig Orfield, HELP's communications director, says the amendment is not meant to mandate the use of one particular type of technology. Rather, he explains, it is designed to allow for the use of either a system similar to that used to authenticate U.S. currency, or an electronic system such as RFID.

Login and post your comment!

Not a member?

Signup for an account now to access all of the features of RFIDJournal.com!

Case Studies Features Best Practices How-Tos
Live Events Virtual Events Webinars
Simply enter a question for our experts.
RFID Journal LIVE! RFID in Health Care LIVE! LatAm LIVE! Brasil LIVE! Europe RFID Connect Virtual Events RFID Journal Awards Webinars Presentations